Trial Profile
Exploratory study of of JTT-751 high dose in Chronic Kidney Disease Patients on Hemodialysis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs Ferric citrate (Primary)
- Indications Kidney disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Japan Tobacco
- 06 Jun 2016 New trial record